-
-
-
-
-
-
-
Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases
-
-
-
-
-
-
-
Kiora Pharmaceuticals (KPRX) Misses Q3 EPS by 81c
-
-
-
-
-
-
-
Kiora Pharmaceuticals Announces Q2 2023 Earnings and Business Update, Highlighting Pipeline Updates and Clinical Development Progress
-
-
-
-
-
-
-
Kiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
1,201,851 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

